Revenio Group Corporation, Press release, April 13, 2022 at 3.00 p.m. (EEST)

Revenio Group Corporation’s January-March 2022 Interim Report will be published on Thursday April 28, 2022, approximately at 09.00 a.m. (EEST). The report will be available at https://www.reveniogroup.fi/en/investors/reports_and_presentations

An audiocast and conference call for analysts and investors will be held in English at 3.00 p.m. (EEST) on the same day.

Link to the event: https://revenio.videosync.fi/results-q1-2022

Dial in numbers for the conference call:
Finland: +358 9 8171 0310
Sweden: +46 8 5664 2651
United Kingdom: +44 33 3300 0804
United States: +1 63 1913 1422

PIN: 77956089#

For further information, please contact
Robin Pulkkinen, CFO, tel. +358 50 505 9932
robin.pulkkinen@revenio.fi
www.reveniogroup.fi/en/

Distribution
Key media
www.reveniogroup.fi/en

Revenio Group in brief
Revenio is a leading company in the global market for ophthalmological devices and software solutions. Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), perimeter and fundus imaging devices under the iCare brand. In addition, the Group’s eye care software platform Oculo offers clinical communication, telehealth, remote patient monitoring and data analytics capabilities.

In 2021, the Group’s net sales totaled EUR 78.8 million, with an operating profit of EUR 22.1 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.

Attachments

Invitation to Revenio Group Corporation’s audiocast and conference call

© Modular Finance, source Nordic Press Releases